The William Davidson Institute
The William Davidson Institute
The William Davidson Institute
The William Davidson Institute About WDI Contact WDI Site Index

Health

PARTNERSHIPS
Manzoor Ahmed. In Wang, Yidan Ed. “Public Private Partnerships in the Social Sector: Issues and Country Experiences in Asia and the Pacific.” Asian Development Bank Institute Policy Series No. 1, 2000.

Discusses BRAC, Grameen Bank, and other health care NGOs engaged in partnership with corporations.
 

 
Diana Barrett et al.
 
Paper presented at the Workshop on Public-Private Partnerships in Public Health, April 7-8th, 2000.  Discusses the partnership between the Edna McConnell Clark Foundation and Pfizer, Inc. to form the International Trachoma Initiative (ITI), a non-profit organization dedicated to implementing a multi-faceted strategy to combat trachoma.
 

 
Sania Nishtar, Health Research Policy & Systems, 2004

Outlines key ethical and procedural issues inherent in different types of public-private arrangements and issues a Global Call to Action.



“Pfizer Global Health Fellows: Expanding Access to Healthcare Through Cross-Sector Partnerships” 
Jonathan B. Levine, Boston College Center for Corporate Citizenship, 2004

Highlights the work that Pfizer Fellows have been doing with various NGOs in the developing countries. It also discusses the inception of the Pfizer Fellows Program.


 
A partnership of 315 non-profit organizations and corporations, sponsored by the World Health Organization, dedicated to combating Tuberculosis. 
 

 
 
According to the their website, “The Global Alliance to Eliminate Lymphatic Filariasis is a free, non-restrictive partnership forum for the exchange of ideas and coordination of activities, with membership open to all interested parties. Its functions include: sharing of information on progress and challenges, coordination of activities (such as fund-raising) and advocacy. To date the Global Alliance to Eliminate Lymphatic Filariasis includes non-governmental organizations, private corporations, and governments.”
 

  
The ILEP, in partnership with World Health Organization, the Nippon Foundation, and the Swiss pharmaceutical group Novartis AG, are actively working to end leprosy.
 

 
Marc J. Roberts et al.
 
Paper was presented at the Workshop on Public-Private Partnerships in Public Health, April 7-8th, 2000.  Addresses important questions and counter arguments regarding what makes partnerships ethical, the rights and responsibilities that corporations face in a partnership, and the role that profits play in obtaining “social good”.
 
 
COMMERCIAL SUSTAINABILITY
 
 
According to PSI’s website, “PSI is a non-profit organization that harnesses the viability of the private, commercial sector to address health problems, with programs in safe water, malaria, micronutrients, family planning and HIV/AIDS in more than 70 countries. PSI collaborates with some of the world’s largest corporations to implement workplace health programs. For example, Coca-Cola transports condoms in South Africa. ChevronTexaco, ExxonMobile, Esso, BP, Marathon Oil Company, and Pfizer have been instrumental in increasing HIV/AIDS awareness.”
 

  
Anna Benton, Commercial Market Strategies (CMS) Paper, February 2004
 
Addresses the public-private partnerships between the Commercial Market Strategies (CMS) and a number of NGOs working in the reproductive health sector.  CMS provides sustainability assistance to NGOs in 12 countries and holds regional sustainability workshops in Africa, Latin America, and the Arab world, and is considered a leader in private-sector approaches to reproductive health.